Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
Depression is a chronic and debilitating illness that interferes severely with many human behaviors, and is the leading cause of disability in the world. There is data suggesting that deficits in serotonin neurotransmission can contribute to the development of depression. Indeed, >90% of prescrib...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/201768 |
| Acceso en línea: | http://hdl.handle.net/10261/201768 |
| Access Level: | acceso abierto |
| Palabra clave: | Depression Raphe Serotonin Noradrenaline Glutamate |
| id |
ES_ccdee36077109abbc8de1491c91f9632 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/201768 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of KetamineLópez-Gil, XavierJiménez-Sánchez, LauraCampa, LeticiaCastro, ElenaFrago, ClaraAdell, AlbertDepressionRapheSerotoninNoradrenalineGlutamateDepression is a chronic and debilitating illness that interferes severely with many human behaviors, and is the leading cause of disability in the world. There is data suggesting that deficits in serotonin neurotransmission can contribute to the development of depression. Indeed, >90% of prescribed antidepressant drugs act by increasing serotonergic transmission at the synapse. However, this increase is offset by a negative feedback operating at the level of the cell body of the serotonin neurons in the raphe nuclei. In the present work, we demonstrate: first, the intracortical infusion of ketamine induced an antidepressant-like effect in the forced swim test, comparable to that produced by systemic ketamine; second, systemic and intracortical ketamine increased serotonin and noradrenaline efflux in the prefrontal cortex, but not in the dorsal raphe nucleus; third, systemic and intracortical administration of ketamine increased the efflux of glutamate in the prefrontal cortex and dorsal raphe nucleus; fourth, systemic ketamine did not alter the functionality of 5-HT1A receptors in the dorsal raphe nucleus. Taken together, these findings suggest that the antidepressant-like effects of ketamine are caused by the stimulation of the prefrontal projection to the dorsal raphe nucleus and locus coeruleus caused by an elevated glutamate in the medial prefrontal cortex, which would stimulate release of serotonin and noradrenaline in the same area. The impact of both monoamines in the antidepressant response to ketamine seems to have different time frames.This work was supported by the Instituto de Salud Carlos III, Subdirección General del Evaluación y Fomento de la Investigacion (FIS Grants PI13-00038 and PI16-00217) that ́ were cofunded by the European Regional Development Fund (“A way to build Europe”). Funding from the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM) ́ is also acknowledged. We also acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).American Chemical SocietyInstituto de Salud Carlos IIIEuropean CommissionCentro de Investigación Biomédica en Red Salud Mental (España)CSIC - Unidad de Recursos de Información Científica para la Investigación (URICI)Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2020202020192020info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/201768reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.1021/acschemneuro.9b00288Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2017682026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| title |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| spellingShingle |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine López-Gil, Xavier Depression Raphe Serotonin Noradrenaline Glutamate |
| title_short |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| title_full |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| title_fullStr |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| title_full_unstemmed |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| title_sort |
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine |
| dc.creator.none.fl_str_mv |
López-Gil, Xavier Jiménez-Sánchez, Laura Campa, Leticia Castro, Elena Frago, Clara Adell, Albert |
| author |
López-Gil, Xavier |
| author_facet |
López-Gil, Xavier Jiménez-Sánchez, Laura Campa, Leticia Castro, Elena Frago, Clara Adell, Albert |
| author_role |
author |
| author2 |
Jiménez-Sánchez, Laura Campa, Leticia Castro, Elena Frago, Clara Adell, Albert |
| author2_role |
author author author author author |
| dc.contributor.none.fl_str_mv |
Instituto de Salud Carlos III European Commission Centro de Investigación Biomédica en Red Salud Mental (España) CSIC - Unidad de Recursos de Información Científica para la Investigación (URICI) Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Depression Raphe Serotonin Noradrenaline Glutamate |
| topic |
Depression Raphe Serotonin Noradrenaline Glutamate |
| description |
Depression is a chronic and debilitating illness that interferes severely with many human behaviors, and is the leading cause of disability in the world. There is data suggesting that deficits in serotonin neurotransmission can contribute to the development of depression. Indeed, >90% of prescribed antidepressant drugs act by increasing serotonergic transmission at the synapse. However, this increase is offset by a negative feedback operating at the level of the cell body of the serotonin neurons in the raphe nuclei. In the present work, we demonstrate: first, the intracortical infusion of ketamine induced an antidepressant-like effect in the forced swim test, comparable to that produced by systemic ketamine; second, systemic and intracortical ketamine increased serotonin and noradrenaline efflux in the prefrontal cortex, but not in the dorsal raphe nucleus; third, systemic and intracortical administration of ketamine increased the efflux of glutamate in the prefrontal cortex and dorsal raphe nucleus; fourth, systemic ketamine did not alter the functionality of 5-HT1A receptors in the dorsal raphe nucleus. Taken together, these findings suggest that the antidepressant-like effects of ketamine are caused by the stimulation of the prefrontal projection to the dorsal raphe nucleus and locus coeruleus caused by an elevated glutamate in the medial prefrontal cortex, which would stimulate release of serotonin and noradrenaline in the same area. The impact of both monoamines in the antidepressant response to ketamine seems to have different time frames. |
| publishDate |
2019 |
| dc.date.none.fl_str_mv |
2019 2020 2020 2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/201768 |
| url |
http://hdl.handle.net/10261/201768 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/10.1021/acschemneuro.9b00288 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
American Chemical Society |
| publisher.none.fl_str_mv |
American Chemical Society |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419758791688192 |
| score |
15,81155 |